Company: PIII
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001140361-25-016302
Chunk: 51

Company: P3 Health Partners Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 51
---
1) | Amounts reflect the grant date fair value of the option awards granted to the non-employee directors, as computed in accordance with FASB ASC Topic 718, but excluding any impact of estimated forfeiture rates as required by SEC regulations. We provide information regarding the assumptions used to calculate the value of all equity awards granted to executives and directors in 2024 in Note 15 to the consolidated financial statements included in our 2024 Form 10-K. The table below shows the aggregate number of vested and unvested stock option awards and unvested RSUs held as of December 31, 2024 by each director. The information in the table below does not reflect the Reverse Stock Split. |

| Name                |     |    Number of Class A 
   Shares (Vested and 
 Unvested) Underlying 
        Stock Options 
               (#)(1) |     |     Number of 
 Unvested RSUs 
        (#)(1) |
| Mark Thierer        |     |            1,336,348 |     |       216,561 |
| Gregory N. Kazarian |     |              568,175 |     |       108,281 |
| Lawrence B. Leisure |     |              568,175 |     |       108,281 |
| Jeffrey G. Park     |     |              568,175 |     |       108,281 |
| Thomas E. Price     |     |              568,175 |     |       108,281 |
| Mary A. Tolan       |     |              568,175 |     |       108,281 |
| Greg Wasson         |     |              568,175 |     |       108,281 |

| (1) | Amounts in this column do not reflect the Reverse Stock Split. |

35

TABLE OF CONTENTS

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT The following table sets forth certain information with respect to holdings of our Class A common stock and Class V common stock by:

| • | stockholders who beneficially owned more than 5% of the outstanding shares of our Class A common stock or Class V common stock; |

| • | each of our named executive officers and directors; and |

| • | all directors and executive officers as a group. |

The number of shares beneficially owned by each stockholder is determined under rules issued by the SEC and includes voting or investment power with respect to